Anticancer potential of nerolidol on acute lymphoblastic leukemia cells through the interactions with the NF-κB/STAT-3 and PI3K/Akt signaling pathways

Our results suggest that NRD treatment stimulates apoptosis in MOLT-4 cells by causing the accumulation of intracellular ROS through PI3K/AKT/STAT-3 signaling pathways.

Authors

Institutions

Publication Details

Journal
Advances in Clinical and Experimental Medicine
Published
2025-01-16
DOI
https://doi.org/10.17219/acem/192695
Primary Topic
Synthesis and biological activity
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Anticancer potential of nerolidol on acute lymphoblastic leukemia cells through the interactions with the NF-κB/STAT-3 and PI3K/Akt signaling pathways

Hengfei Du, Xuejiao Wang, Ke Wang
Advances in Clinical and Experimental Medicine
Synthesis and biological activity
article

Anticancer potential of nerolidol on acute lymphoblastic leukemia cells through the interactions with the NF-κB/STAT-3 and PI3K/Akt signaling pathways

Hengfei Du, Xuejiao Wang, Ke Wang
article en

Abstract

Our results suggest that NRD treatment stimulates apoptosis in MOLT-4 cells by causing the accumulation of intracellular ROS through PI3K/AKT/STAT-3 signaling pathways.

Advances in Clinical and Experimental MedicineVol. 34(9)
China XD Group (China) (CN)
Openalex Percentile: Top 99%
Synthesis and biological activity
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Anticancer potential of nerolidol on acute lymphoblastic leukemia cells through the interactions with the NF-κB/STAT-3 and PI3K/Akt signaling pathways — Hengfei Du, Xuejiao Wang, et al. · Advances in Clinical and Experimental Medicine (2025) | TGRS Research Map | TGRS